Suppr超能文献

后葡萄膜黑色素瘤的等位基因型:对肿瘤分叉进展途径的影响

Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway.

作者信息

Parrella P, Sidransky D, Merbs S L

机构信息

Dipartimento Ricerca BioMedica, University Campus Bio Medico, Rome, Italy.

出版信息

Cancer Res. 1999 Jul 1;59(13):3032-7.

Abstract

To further elucidate the somatic genetic alterations leading to acquired choroidal and ciliochoroidal melanoma, we screened every autosomal arm and the X chromosome of 50 primary posterior melanomas (31 choroidal tumors and 19 ciliochoroidal tumors). A minimum of two microsatellite markers were used to achieve at least 90% informativity (excluding X). Twenty-eight of 47 informative tumors (59%) showed allelic loss of all informative markers on chromosome 3, consistent with monosomy 3 (M3). Allelic imbalance of 8q was observed in 60% of tumors. A total of 28% of tumors displayed allelic loss of 6p. We then compared these genetic alterations with the status of chromosome 3 and found a relative absence of 6p alteration in tumors with M3 (P = 0.0005). Additionally, all observed 8q imbalance was associated with either M3 or alteration of 6p, suggesting that 8q alterations occur later in tumor progression. The mutual exclusivity of M3 and 6p alterations suggests a bifurcated tumor progression model. In this model, M3 or 6p loss identify distinct pathways, both followed by 8q loss in tumor progression.

摘要

为了进一步阐明导致获得性脉络膜和睫状体脉络膜黑色素瘤的体细胞基因改变,我们对50例原发性后部黑色素瘤(31例脉络膜肿瘤和19例睫状体脉络膜肿瘤)的每一条常染色体臂和X染色体进行了筛查。至少使用两个微卫星标记以达到至少90%的信息性(不包括X染色体)。47例信息性肿瘤中有28例(59%)显示3号染色体上所有信息性标记的等位基因缺失,与3号染色体单体性(M3)一致。60%的肿瘤观察到8q等位基因失衡。共有28%的肿瘤显示6p等位基因缺失。然后我们将这些基因改变与3号染色体状态进行比较,发现M3肿瘤中6p改变相对较少(P = 0.0005)。此外,所有观察到的8q失衡都与M3或6p改变相关,提示8q改变发生在肿瘤进展的后期。M3和6p改变的相互排斥性提示了一种分叉的肿瘤进展模型。在这个模型中,M3或6p缺失确定了不同的途径,两者在肿瘤进展中都随后出现8q缺失。

引用本文的文献

1
Genetics and RNA Regulation of Uveal Melanoma.
Cancers (Basel). 2023 Jan 26;15(3):775. doi: 10.3390/cancers15030775.
2
Choroidal biopsies; a review and optimised approach.
Eye (Lond). 2023 Apr;37(5):900-906. doi: 10.1038/s41433-022-02194-0. Epub 2022 Aug 8.
3
Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis.
Front Oncol. 2022 Apr 11;12:828112. doi: 10.3389/fonc.2022.828112. eCollection 2022.
4
Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma.
Mol Biomed. 2021 Aug 20;2(1):25. doi: 10.1186/s43556-021-00048-x.
5
Small High-Risk Uveal Melanomas Have a Lower Mortality Rate.
Cancers (Basel). 2021 May 8;13(9):2267. doi: 10.3390/cancers13092267.
6
Molecular characteristics of uveal melanoma and intraocular tumors.
Oncol Lett. 2021 Jan;21(1):9. doi: 10.3892/ol.2020.12270. Epub 2020 Nov 3.
7
Uveal Melanoma: A Review of the Literature.
Oncol Ther. 2018 Jun;6(1):87-104. doi: 10.1007/s40487-018-0056-8. Epub 2018 Feb 6.
8
ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells.
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):132-143. doi: 10.1167/iovs.17-22454.
9
HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
Tumour Biol. 2016 Sep;37(9):12779-12789. doi: 10.1007/s13277-016-5243-3. Epub 2016 Jul 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验